The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats

被引：0
|
作者：
Marco Bortolato
Gian Nicola Aru
Roberto Frau
Marco Orrù
Grant Christopher Luckey
Gianluca Boi
Gian Luigi Gessa
机构：
[1] University of Cagliari,Department of Neuroscience “B.B. Brodie”, Center of Excellence “Neurobiology of Dependence”
[2] Ohio State University,Department of Psychology
来源：
Psychopharmacology | 2005年 / 177卷
关键词：
Cannabinoids; WIN 55,212-2; Prepulse inhibition; Startle reflex Sensorimotor gating;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：264 / 271
页数：7
相关论文
共 50 条
  • [31] Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2
    Castelli, M. Paola
    Piras, A. Paola
    D'Agostino, Antonella
    Pibiri, Fabio
    Perra, Simona
    Gessa, Gian Luigi
    Maccarrone, Mauro
    Pistis, Marco
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 573 (1-3) : 11 - 19
  • [32] The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum
    Pintor, A.
    Tebano, M. T.
    Martire, A.
    Grieco, R.
    Galluzzo, M.
    Scattoni, M. L.
    Pezzola, A.
    Coccurello, R.
    Felici, F.
    Cuomo, V.
    Piomelli, D.
    Calamandrei, G.
    Popoli, P.
    NEUROPHARMACOLOGY, 2006, 51 (05) : 1004 - 1012
  • [33] The effect of spinally administered WIN 55,212-2, a cannabinoid agonist, on thermal pain sensitivity in diabetic rats
    Jahanabadi, Samane
    Hadian, Mohamad Reza
    Shamsaee, Javad
    Tavangar, Seyed Mohammad
    Abdollahi, Alireza
    Dehpour, Ahmadreza
    Mehr, Shahram Ejtemaei
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2016, 19 (04) : 394 - 401
  • [34] CB1 cannabinoid and μ opioid receptors density and functionality are altered in rats self-administering either heroin or the CB1 receptor agonist WIN 55,212-2
    Fattore, L.
    Vigano, D.
    Fadda, P.
    Rubino, T.
    Parolaro, D.
    Fratta, W.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S517 - S518
  • [35] Functional responses to the cannabinoid agonist WIN 55,212-2 in neonatal rats of both genders:: influence of weaning
    Borcel, E
    Pérez-Alvarez, L
    de Ceballos, ML
    Ramirez, BG
    Marco, EM
    Fernández, B
    Rubio, M
    Guaza, C
    Viveros, MP
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2004, 78 (03) : 593 - 602
  • [36] Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice
    Martellotta, MC
    Cossu, G
    Fattore, L
    Gessa, GL
    Fratta, W
    NEUROSCIENCE, 1998, 85 (02) : 327 - 330
  • [37] Behavioral effects in adult rats of chronic treatment with the cannabinoid receptor agonist win 55,212-2 during different phases of development
    Schneider, M
    Drews, E
    Koch, M
    Schömig, E
    Leweke, FM
    BEHAVIOURAL PHARMACOLOGY, 2005, 16 : S57 - S58
  • [38] Antinociceptive synergy between the cannabinoid receptor agonist WIN 55,212-2 and bupivacaine in the rat formalin test
    Kang, Sinyoung
    Kim, Chi Hyo
    Lee, Heeseung
    Kim, Dong Yeon
    Han, Jong In
    Chung, Rack Kyung
    Lee, Guie Yong
    ANESTHESIA AND ANALGESIA, 2007, 104 (03): : 719 - 725
  • [39] Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate γ-aminobutyric acid levels
    Ferraro, L
    Tomasini, MC
    Cassano, T
    Bebe, BW
    Siniscalchi, A
    O'Connor, WT
    Magee, P
    Tanganelli, S
    Cuomo, V
    Antonelli, T
    JOURNAL OF NEUROSCIENCE RESEARCH, 2001, 66 (02) : 298 - 302
  • [40] WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation
    Vlachou, S
    Nomikos, GG
    Panagis, G
    BEHAVIOURAL BRAIN RESEARCH, 2003, 141 (02) : 215 - 222
12345